Joe Cosgrove is the CEO of Pentec Health Incorporated, a specialty sterile compounding pharmacy providing services to patients in the home and other various alternate administration sites. The company is located in Boothwyn, Pennsylvania. Also the chairman of Pentec Health’s board, Joe Cosgrove manages the company’s development strategy and is largely responsible for its newest line of dietary supplements known as Proplete.
Due to its unique composition, Proplete, designed for those who experience problems after hemodialysis, provides benefits to patients with the following conditions:
Chronic Kidney Disease: An estimated 70 percent of patients with chronic kidney disease deal with malnutrition after receiving hemodialysis, which can lead to weight loss and low protein levels. Proplete provides significant doses of protein.
Fluid Management Problems: Patients with advanced cardiac or hepatic disease may experience problems with managing fluids. The low-volume nature of Proplete can help alleviate these concerns.
Obesity: Traditional hemodialysis medications often contain extra calories and lipids in addition to high levels of protein. Proplete contains no lipids and is low in carbohydrates, making it ideal for overweight or obese patients.
Diabetes: Many Intradialytic Parenteral Nutrition (IDPN) supplements require close supervision of blood glucose intake in diabetic patients. The low-dextrin formula of Proplete allows diabetic patients to more easily manage these levels.